{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T05:24:48Z","timestamp":1787030688070,"version":"build-2736575974"},"reference-count":44,"publisher":"Spandidos Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.3892\/or.2015.4496","type":"journal-article","created":{"date-parts":[[2015,12,17]],"date-time":"2015-12-17T07:37:48Z","timestamp":1450337868000},"page":"1582-1592","source":"Crossref","is-referenced-by-count":39,"title":["The anti-diabetic drug metformin inhibits pancreatic cancer cell proliferation in vitro and in vivo: Study of the microRNAs associated with the antitumor effect of metformin"],"prefix":"10.3892","volume":"35","author":[{"given":"KIYOHITO","family":"KATO","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HISAKAZU","family":"IWAMA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"TAKUMA","family":"YAMASHITA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KIYOYUKI","family":"KOBAYASHI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SHINTARO","family":"FUJIHARA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"TAKAYUKI","family":"FUJIMORI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HIDEKI","family":"KAMADA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HIDEKI","family":"KOBARA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"TSUTOMU","family":"MASAKI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2015,12,17]]},"reference":[{"key":"key20180107210627_b1-or-35-03-1582","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1053\/j.gastro.2009.04.013","article-title":"Antidiabetic therapies affect risk of pancreatic cancer","volume":"137","author":"Li","year":"2009","journal-title":"Gastroenterology"},{"key":"key20180107210627_b2-or-35-03-1582","doi-asserted-by":"crossref","first-page":"e33411","DOI":"10.1371\/journal.pone.0033411","article-title":"Cancer risk in diabetic patients treated with metformin: A systematic review and meta-analysis","volume":"7","author":"Noto","year":"2012","journal-title":"PLoS One"},{"key":"key20180107210627_b3-or-35-03-1582","doi-asserted-by":"crossref","first-page":"3576","DOI":"10.1038\/sj.onc.1211024","article-title":"The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level","volume":"27","author":"Ben Sahra","year":"2008","journal-title":"Oncogene"},{"key":"key20180107210627_b4-or-35-03-1582","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s10549-012-2170-x","article-title":"Metformin and breast cancer risk: A meta-analysis and critical literature review","volume":"135","author":"Col","year":"2012","journal-title":"Breast Cancer Res Treat"},{"key":"key20180107210627_b5-or-35-03-1582","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.canep.2012.12.009","article-title":"Association of metformin use with cancer incidence and mortality: A meta-analysis","volume":"37","author":"Zhang","year":"2013","journal-title":"Cancer Epidemiol"},{"key":"key20180107210627_b6-or-35-03-1582","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1053\/j.gastro.2012.02.050","article-title":"Aspirin inhibits mTOR signaling, activates AMP-activated protein kinase, and induces autophagy in colorectal cancer cells","volume":"142","author":"Din","year":"2012","journal-title":"Gastroenterology"},{"key":"key20180107210627_b7-or-35-03-1582","doi-asserted-by":"crossref","first-page":"7192","DOI":"10.3748\/wjg.14.7192","article-title":"Metformin induces apoptosis of pancreatic cancer cells","volume":"14","author":"Wang","year":"2008","journal-title":"World J Gastroenterol"},{"key":"key20180107210627_b8-or-35-03-1582","doi-asserted-by":"crossref","first-page":"6539","DOI":"10.1158\/0008-5472.CAN-09-0418","article-title":"Metformin disrupts crosstalk between G protein-coupled receptor and insulin receptor signaling systems and inhibits pancreatic cancer growth","volume":"69","author":"Kisfalvi","year":"2009","journal-title":"Cancer Res"},{"key":"key20180107210627_b9-or-35-03-1582","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1158\/1535-7163.MCT-11-0594","article-title":"The antidiabetic drug metformin inhibits gastric cancer cell proliferation in vitro and in vivo","volume":"11","author":"Kato","year":"2012","journal-title":"Mol Cancer Ther"},{"key":"key20180107210627_b10-or-35-03-1582","doi-asserted-by":"crossref","first-page":"18255","DOI":"10.1073\/pnas.0608791103","article-title":"A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure","volume":"103","author":"van Rooij","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180107210627_b11-or-35-03-1582","doi-asserted-by":"crossref","first-page":"5848","DOI":"10.1200\/JCO.2009.24.0317","article-title":"MicroRNAs in cancer: Small molecules with a huge impact","volume":"27","author":"Iorio","year":"2009","journal-title":"J Clin Oncol"},{"key":"key20180107210627_b12-or-35-03-1582","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/emmm.201100209","article-title":"MicroRNA dysregulation in cancer: Diagnostics, monitoring and therapeutics. A comprehensive review","volume":"4","author":"Iorio","year":"2012","journal-title":"EMBO Mol Med"},{"key":"key20180107210627_b13-or-35-03-1582","first-page":"661","article-title":"Comparison study of the expressions of myristoylated alanine-rich C kinase substrate in hepatocellular carcinoma, liver cirrhosis, chronic hepatitis, and normal liver","volume":"26","author":"Masaki","year":"2005","journal-title":"Int J Oncol"},{"key":"key20180107210627_b14-or-35-03-1582","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/227680a0","article-title":"Cleavage of structural proteins during the assembly of the head of bacteriophage T4","volume":"227","author":"Laemmli","year":"1970","journal-title":"Nature"},{"key":"key20180107210627_b15-or-35-03-1582","doi-asserted-by":"crossref","first-page":"4350","DOI":"10.1073\/pnas.76.9.4350","article-title":"Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications","volume":"76","author":"Towbin","year":"1979","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180107210627_b16-or-35-03-1582","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3322\/caac.20006","article-title":"Cancer statistics, 2009","volume":"59","author":"Jemal","year":"2009","journal-title":"CA Cancer J Clin"},{"key":"key20180107210627_b17-or-35-03-1582","doi-asserted-by":"crossref","first-page":"4532","DOI":"10.1200\/JCO.2005.17.954","article-title":"Adjuvant treatment for resectable pancreatic cancer","volume":"23","author":"Chua","year":"2005","journal-title":"J Clin Oncol"},{"key":"key20180107210627_b18-or-35-03-1582","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1001\/jama.297.3.267","article-title":"Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: A randomized controlled trial","volume":"297","author":"Oettle","year":"2007","journal-title":"JAMA"},{"key":"key20180107210627_b19-or-35-03-1582","first-page":"936893","article-title":"Novel strategy with gemcitabine for advanced pancreatic cancer","volume":"2011","author":"Komori","year":"2011","journal-title":"ISRN Oncol"},{"key":"key20180107210627_b20-or-35-03-1582","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.drup.2011.04.003","article-title":"Repositioning chloroquine and metformin to eliminate cancer stem cell traits in pre-malignant lesions","volume":"14","author":"Vazquez-Martin","year":"2011","journal-title":"Drug Resist Updat"},{"key":"key20180107210627_b21-or-35-03-1582","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/ajg.2011.483","article-title":"Use of antidiabetic agents and the risk of pancreatic cancer: A case-control analysis","volume":"107","author":"Bodmer","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"key20180107210627_b22-or-35-03-1582","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.4161\/cc.8.13.8814","article-title":"Metformin induces unique biological and molecular responses in triple negative breast cancer cells","volume":"8","author":"Liu","year":"2009","journal-title":"Cell Cycle"},{"key":"key20180107210627_b23-or-35-03-1582","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/00006676-200110000-00009","article-title":"Epidermal growth factor induces cyclin D1 in human pancreatic carcinoma: Evidence for a cyclin D1-dependent cell cycle progression","volume":"23","author":"Poch","year":"2001","journal-title":"Pancreas"},{"key":"key20180107210627_b24-or-35-03-1582","doi-asserted-by":"crossref","first-page":"8335","DOI":"10.1074\/jbc.274.12.8335","article-title":"c-Src-mediated phosphorylation of the epidermal growth factor receptor on Tyr845 and Tyr1101 is associated with modulation of receptor function","volume":"274","author":"Biscardi","year":"1999","journal-title":"J Biol Chem"},{"key":"key20180107210627_b25-or-35-03-1582","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1159\/000066230","article-title":"The role of the IGF system in cancer: From basic to clinical studies and clinical applications","volume":"63","author":"Moschos","year":"2002","journal-title":"Oncology"},{"key":"key20180107210627_b26-or-35-03-1582","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1023\/A:1021779624971","article-title":"Antiproliferative and proapoptotic effect of ascorbyl stearate in human pancreatic cancer cells: Association with decreased expression of insulin-like growth factor 1 receptor","volume":"48","author":"Naidu","year":"2003","journal-title":"Dig Dis Sci"},{"key":"key20180107210627_b27-or-35-03-1582","first-page":"6432","article-title":"Genetic blockade of the insulin-like growth factor-I receptor: A promising strategy for human pancreatic cancer","volume":"63","author":"Min","year":"2003","journal-title":"Cancer Res"},{"key":"key20180107210627_b28-or-35-03-1582","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.bbrc.2009.12.182","article-title":"MiR-150 promotes gastric cancer proliferation by negatively regulating the pro-apoptotic gene EGR2","volume":"392","author":"Wu","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"key":"key20180107210627_b29-or-35-03-1582","first-page":"739","article-title":"MicroRNA expression profiles in human colorectal cancers with liver metastases","volume":"25","author":"Lin","year":"2011","journal-title":"Oncol Rep"},{"key":"key20180107210627_b30-or-35-03-1582","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/leu.2011.81","article-title":"The role of microRNA-150 as a tumor suppressor in malignant lymphoma","volume":"25","author":"Watanabe","year":"2011","journal-title":"Leukemia"},{"key":"key20180107210627_b31-or-35-03-1582","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1093\/carcin\/bgr223","article-title":"MicroRNA-150 directly targets MUC4 and suppresses growth and malignant behavior of pancreatic cancer cells","volume":"32","author":"Srivastava","year":"2011","journal-title":"Carcinogenesis"},{"key":"key20180107210627_b32-or-35-03-1582","doi-asserted-by":"crossref","first-page":"28274","DOI":"10.1074\/jbc.M802663200","article-title":"MicroRNAs miR-186 and miR-150 down-regulate expression of the pro-apoptotic purinergic P2X7 receptor by activation of instability sites at the 3\u2032-untranslated region of the gene that decrease steady-state levels of the transcript","volume":"283","author":"Zhou","year":"2008","journal-title":"J Biol Chem"},{"key":"key20180107210627_b33-or-35-03-1582","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1093\/molbev\/msn165","article-title":"c-Myb is an evolutionary conserved miR-150 target and miR-150\/c-Myb interaction is important for embryonic development","volume":"25","author":"Lin","year":"2008","journal-title":"Mol Biol Evol"},{"key":"key20180107210627_b34-or-35-03-1582","first-page":"747","article-title":"microRNA-150 inhibits human CD133-positive liver cancer stem cells through negative regulation of the transcription factor c-Myb","volume":"40","author":"Zhang","year":"2012","journal-title":"Int J Oncol"},{"key":"key20180107210627_b35-or-35-03-1582","doi-asserted-by":"crossref","first-page":"5731","DOI":"10.1074\/jbc.M804280200","article-title":"Regulation of epidermal growth factor receptor signaling in human cancer cells by microRNA-7","volume":"284","author":"Webster","year":"2009","journal-title":"J Biol Chem"},{"key":"key20180107210627_b36-or-35-03-1582","doi-asserted-by":"crossref","first-page":"25377","DOI":"10.1074\/jbc.M111.222760","article-title":"Usp18 regulates epidermal growth factor (EGF) receptor expression and cancer cell survival via microRNA-7","volume":"286","author":"Duex","year":"2011","journal-title":"J Biol Chem"},{"key":"key20180107210627_b37-or-35-03-1582","doi-asserted-by":"crossref","first-page":"8822","DOI":"10.1158\/0008-5472.CAN-10-0638","article-title":"EGFR promotes lung tumorigenesis by activating miR-7 through a Ras\/ERK\/Myc pathway that targets the Ets2 transcriptional repressor ERF","volume":"70","author":"Chou","year":"2010","journal-title":"Cancer Res"},{"key":"key20180107210627_b38-or-35-03-1582","doi-asserted-by":"crossref","first-page":"F19","DOI":"10.1677\/ERC-09-0184","article-title":"The role of let-7 in cell differentiation and cancer","volume":"17","author":"Boyerinas","year":"2010","journal-title":"Endocr Relat Cancer"},{"key":"key20180107210627_b39-or-35-03-1582","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.cell.2005.01.014","article-title":"RAS is regulated by the let-7 microRNA family","volume":"120","author":"Johnson","year":"2005","journal-title":"Cell"},{"key":"key20180107210627_b40-or-35-03-1582","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1101\/gad.1540407","article-title":"The tumor suppressor microRNA let-7 represses the HMGA2 oncogene","volume":"21","author":"Lee","year":"2007","journal-title":"Genes Dev"},{"key":"key20180107210627_b41-or-35-03-1582","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1349-7006.2010.01707.x","article-title":"let-7 and miR-17-92: Small-sized major players in lung cancer development","volume":"102","author":"Osada","year":"2011","journal-title":"Cancer Sci"},{"key":"key20180107210627_b42-or-35-03-1582","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/ijc.25336","article-title":"Hsa-let-7g inhibits proliferation of hepatocellular carcinoma cells by downregulation of c-Myc and upregulation of p16INK4A","volume":"128","author":"Lan","year":"2011","journal-title":"Int J Cancer"},{"key":"key20180107210627_b43-or-35-03-1582","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.yexcr.2010.11.004","article-title":"Let-7b-mediated suppression of basigin expression and metastasis in mouse melanoma cells","volume":"317","author":"Fu","year":"2011","journal-title":"Exp Cell Res"},{"key":"key20180107210627_b44-or-35-03-1582","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/cr.2008.45","article-title":"MicroRNA let-7b targets important cell cycle molecules in malignant melanoma cells and interferes with anchorage-independent growth","volume":"18","author":"Schultz","year":"2008","journal-title":"Cell Res"}],"container-title":["Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/or.2015.4496\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,7]],"date-time":"2018-01-07T16:06:38Z","timestamp":1515341198000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/or.2015.4496"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,17]]},"references-count":44,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2015,12,17]]},"published-print":{"date-parts":[[2016,3]]}},"alternative-id":["10.3892\/or.2015.4496"],"URL":"https:\/\/doi.org\/10.3892\/or.2015.4496","relation":{},"ISSN":["1021-335X","1791-2431"],"issn-type":[{"value":"1021-335X","type":"print"},{"value":"1791-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,17]]}}}